Selected Papers from the 14th International Symposium on Marine Natural Products
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 November 2013) | Viewed by 180920
Special Issue Editors
2. Department of Organic Chemistry, University of Barcelona, Barcelona, Spain
Interests: antimicrobial peptides; solid-phase chemistry; combinatorial chemistry; drug delivery systems; peptide drug conjugates; orthogonal chemistry; drug discovery; biomaterials
Special Issues, Collections and Topics in MDPI journals
Interests: marine natural products
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Natural marine compounds have interesting and diverse biological profiles, including bioactive properties, such as anti-tumor, anti-microtubule, anti-proliferative, anti-hypertensive, anti-inflammatory, anti-virus, anti-fungal, cytotoxic, and antibiotic activity.
The efforts channeled into drug development from marine sources have started to bear fruits. Thus, in the last decade, four drugs, Prialt, Eribulin, Adcetris and Yondelis have reached the market, and more importantly, many others are in clinical trials.
The second week of September, the 14th International Symposium on Marine Natural Products and the 8th European Conference on Marine Natural Products will take place in La Toja Island (Galicia, Spain). During these days collages from around the world will present and discuss recent work and ideas covering all areas related to marine natural products.
Marine Drugs is setting up a special issue on "Selected Papers from the 14th International Symposium on Marine Natural Products" which will cover the main highlights presented in the conference.
Carmen Cuevas
Fernando Albericio
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript.
The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs).
Submitted papers should be well formatted and use good English. Authors may use MDPI's
English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.